Royalty Pharma
RPRX
$28.07
Share price
-1.09%
Change (1 day)
-18.23%
Change (1 year)
Categories
Royalty Pharma (RPRX) Fails to deliver data
Key failure to deliver metrics for Royalty Pharma:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $1.66 M
- Last year FTD volume: $18.35 M
Failures to deliver for Royalty Pharma (RPRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Royalty Pharma (RPRX) - since 2020
Volume in USD (price x number of shares), data since 2020Royalty Pharma (RPRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $1.69 M | -91.22% |
| 2023 | $19.26 M | -64.47% |
| 2022 | $54.22 M | -15.8% |
| 2021 | $64.39 M | 67.97% |
| 2020 | $38.33 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $62.38 M | $0.13 B | 🇺🇸 USA |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.16 M | $1.24 M | 🇺🇸 USA |